You are here

  • Home
  • Archive
  • Volume 9, Issue 10
  • Combined inhibition of CXCL12 and PD-1 in MSS colorectal and pancreatic cancer: modulation of the microenvironment and clinical effects

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Combined inhibition of CXCL12 and PD-1 in MSS colorectal and pancreatic cancer: modulation of the microenvironment and clinical effects

 

Online download statistics by month:

Online download statistics by month: October 2021 to July 2025

AbstractFullPdf
Oct 202110391042350
Nov 2021605604193
Dec 2021208214109
Jan 202219219862
Feb 202210110456
Mar 202217417561
Apr 202216116752
May 2022919346
Jun 202217818074
Jul 202214314647
Aug 202210110338
Sep 202212512555
Oct 202215415961
Nov 202212312453
Dec 2022727335
Jan 2023899243
Feb 2023747620
Mar 2023808131
Apr 2023717138
May 2023576032
Jun 2023525212
Jul 2023818134
Aug 2023696944
Sep 202315815861
Oct 202321021038
Nov 202328428419
Dec 2023646431
Jan 2024444525
Feb 2024626423
Mar 2024899029
Apr 2024596027
May 2024626431
Jun 2024464731
Jul 2024666829
Aug 2024818324
Sep 2024555925
Oct 2024727235
Nov 2024818235
Dec 202410410531
Jan 2025999928
Feb 202513513525
Mar 2025464628
Apr 2025999954
May 2025596037
Jun 2025565626
Jul 2025110
Total607261402238